| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0065 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-08 |
| filingDate |
2002-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a19d49609d128da8af57ad80670008f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65cb11a57d58df6fd44999b25760886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c74bf9a65acce863232a8d4dd561925f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_247676ed3b36eb6c01bb121e1757a41a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dc1f18eaeb7f6973f3a3bfae5ca707c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_556ecbfafab1c8528d17705dbcf45dab |
| publicationDate |
2004-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2848566-A1 |
| titleOfInvention |
EPITOPIC PEPTIDES OF ENZYME THYROPEROXIDASE, THE COMPOSITIONS CONTAINING SAME AND THEIR APPLICATIONS |
| abstract |
The present invention relates to purified peptides of 5 to 20 amino acids recognized by the autoantibodies directed against human thyroperoxidase, said peptides constituting discontinuous epitopes originating from the discontinuous immunodominant region of human thyroperoxidase consisting of four distinct regions of TPO belonging to the counterparts of DFO and CPC. The invention also relates to antibodies directed against these peptides and the applications of these peptides and antibodies in particular for the detection of autoantibodies against human thyroperoxidase. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201600120204-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018096512-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105087512-A |
| priorityDate |
2002-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |